Insulin resistance is an intrinsic defect independent of fat mass in women with Turner's syndrome

Hormone Research

Volumn 65, Issue 2, 2006, Pages 69-75

  Salgin, Burak ^a   Amin, Rakesh ^a   Yuen, Kevin ^a   Williams, Rachel M ^a   Murgatroyd, Peter ^a   Dunger, David B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Body composition; Insulin resistance; Turner's syndrome

Indexed keywords

ESTROGEN; FAT; GLUCOSE; GROWTH HORMONE; INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEIGHT; HOMEOSTASIS; HORMONE SUBSTITUTION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; KARYOTYPE; MEASUREMENT; MULTIPLE REGRESSION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TURNER SYNDROME;

ADOLESCENT; ADULT; BODY COMPOSITION; CASE-CONTROL STUDIES; CHOLESTEROL; ESTROGENS; FASTING; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; REGRESSION ANALYSIS; TURNER SYNDROME;

EID: 33344464934     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090907     Document Type: Article

References (45)

1. Gravholt CH, Juul S, Naeraa RW, Hansen J: Morbidity in Turner syndrome. J Clin Epidemiol 1998;51:147-158.
2. Price WH, Clayton JF, Collyer S, De Mey R, Wilson J: Mortality ratios, life expectancy, and causes of death in patients with Turner's syndrome. J Epidemiol Community Health 1986; 40:97-102.
3. Polychronakos C, Letarte J, Collu R, Ducharme JR: Carbohydrate intolerance in children and adolescents with Turner syndrome. J Pediatr 1980;96:1009-1014.
4. Rasio E, Antaki A, Van Campenhout J: Diabetes mellitus in gonadal dysgenesis: studies of insulin and growth hormone secretion. Eur J Clin Invest 1976;6:59-66.
5. Stoppoloni G, Prisco F, Alfano C, Iafusco D, Marrazzo G, Paolisso G: Characteristics of insulin resistance in Turner syndrome. Diabetes Metab 1990;16:267-271.
6. Gravholt CH, Naeraa RW, Nyholm B, Gerdes LU, Christiansen E, Schmitz O, Christiansen JS: Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care 1998;21:1062-1070.
7. Holl RW, Kunze D, Etzrodt H, Teller W, Heinze E: Turner syndrome: final height, glucose tolerance, bone density and psychosocial status in 25 adult patients. Eur J Pediatr 1994; 153:11-16.
8. Caprio S, Boulware S, Diamond M, Sherwin RS, Carpenter TO, Rubin K, Amiel S, Press M, Tamborlane WV: Insulin resistance: an early metabolic defect of Turner's syndrome. J Clin Endocrinol Metab 1991;72:832-836.
9. AvRuskin TW, Crigler JF Jr, Soeldner JS: Turner's syndrome and carbohydrate metabolism. I. Impaired insulin secretion after tolbutamide and glucagon stimulation tests: evidence of insulin deficiency. Am J Med Sci 1979;277:145-152.
10. Bakalov VK, Cooley MM, Quon MJ, Luo ML, Yanovski JA, Nelson LM, Sullivan G, Bondy CA: Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab 2004;89:3516-3520.
11. Gravholt CH, Naeraa RW, Brixen K, Kastrup KW, Mosekilde L, Jorgensen JO, Christiansen JS: Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study. Pediatrics 2002;110:889-896.
12. Neufeld ND, Lippe B, Sperling MA: Carbohydrate intolerance in gonadal dysgenesis: a new model of insulin resistance. Diabetes 1980; 25(suppl):379.
13. Landin-Wilhelmsen K, Bryman I, Wilhelmsen L: Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. J Clin Endocrinol Metab 2001;86:4166-4170.
14. Gravholt CH, Nyholm B, Saltin B, Schmitz O, Christiansen JS: Muscle fiber composition and capillary density in Turner syndrome: evidence of increased muscle fiber size related to insulin resistance. Diabetes Care 2001;24: 1668-1673.
15. Taylor RW, Keil D, Gold EJ, Williams SM, Goulding A: Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am J Clin Nutr 1998;67:44-49.
16. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
17. Campbell PJ, Mandarino LJ, Gerich JE: Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism 1988; 37:15-21.
18. DeFronzo RA, Ferrannini E, Simonson DC: Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 1989;38: 387-395.
19. Levy JC, Matthews DR, Hermans MP: Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191-2192.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
21. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63.
22. Haffner SM, Miettinen H, Stern MP: The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997;20:1087-1092.
23. Hermans MP, Levy JC, Morris RJ, Turner RC: Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 1999;42:678-687.
24. Elsheikh M, Bird R, Casadei B, Conway GS, Wass JA: The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner's syndrome. J Clin Endocrinol Metab 2000;85:614-618.
25. Sylven L, Hagenfeldt K, Brondum-Nielsen K, von Schoultz B: Middle-aged women with Turner's syndrome. Medical status, hormonal treatment and social life. Acta Endocrinol (Copenh) 1991;125:359-365.
26. van Teunenbroek A, de Muinck Keizer-Schrama SM, Aanstoot HJ, Stijnen T, Hoogerbrugge N, Drop SL: Carbohydrate and lipid metabolism during various growth hormone dosing regimens in girls with Turner syndrome. Dutch Working Group on Growth Hormone. Metabolism 1999;48:7-14.
27. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ: Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002;359:1740-1745.
28. Sesti G, Sciacqua A, Cardellini M, Marini MA, Maio R, Vatrano M, Succurro E, Lauro R, Federici M, Perticone F: Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. Diabetes Care 2005;28:120-125.
29. Cusi K, DeFronzo R: Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance. J Clin Endocrinol Metab 2000;85: 3077-3084.
30. Moses AC, Morrow LA, O'Brien M, Moller DE, Flier JS: Insulin-like growth factor I (rhIGF-I) as a therapeutic agent for hyperinsulinemic insulin-resistant diabetes mellitus. Diabetes Res Clin Pract 1995;28(suppl):S185-S194.
31. Morrow LA, O'Brien MB, Moller DE, Flier JS, Moses AC: Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance. J Clin Endocrinol Metab 1994;79:205-210.
32. Schoenle EJ, Zenobi PD, Torresani T, Werder EA, Zachmann M, Froesch ER: Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance. Diabetologia 1991; 34:675-679.
33. Hochberg Z, Aviram M, Rubin D, Pollack S: Decreased sensitivity to insulin-like growth factor I in Turner's syndrome: a study of monocytes and T lymphocytes. Eur J Clin Invest 1997;27:543-547.
34. Janssen JA, Lamberts SW: Is the measurement of free IGF-I more indicative than that of total IGF-I in the evaluation of the biological activity of the GH/IGF-I axis? J Endocrinol Invest 1999;22:313-315.
35. Gravholt CH, Frystyk J, Flyvbjerg A, Orskov H, Christiansen JS: Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids. Am J Physiol Endocrinol Metab 2001;280:E308-E314.
36. Kannel WB, Dawber TR, Thomas HE Jr, McNamara PM: Comparison of serum lipids in the prediction of coronary heart disease. Framingham Study indicates that cholesterol level and blood pressure are major factors in coronary heart disease; effect of obesity and cigarette smoking also noted. R I Med J 1965;48: 243-250.
37. Thomas HE Jr, Kannel WB, Dawber TR, McNamara PM: Cholesterol-phospholipid ratio in the prediction of coronary heart disease. The Framingham Study. N Engl J Med 1966;274: 701-705.
38. Garden AS, Diver MJ, Fraser WD: Undiagnosed morbidity in adult women with Turner's syndrome. Clin Endocrinol (Oxf) 1996;45: 589-593.
39. Ross JL, Feuillan P, Long LM, Kowal K, Kushner H, Cutler GB Jr: Lipid abnormalities in Turner syndrome. J Pediatr 1995;126:242-245.
40. Lanes R, Gunczler P, Palacios A, Villaroel O: Serum lipids, lipoprotein lp(a), and plasminogen activator inhibitor-1 in patients with Turner's syndrome before and during growth hormone and estrogen therapy. Fertil Steril 1997; 68:473-477.
41. Elsheikh M, Conway GS: The impact of obesity on cardiovascular risk factors in Turner's syndrome. Clin Endocrinol (Oxf) 1998;49: 447-450.
42. Cicognani A, Mazzanti L, Tassinari D, Pellacani A, Forabosco A, Landi L, Pifferi C, Cacciari E: Differences in carbohydrate tolerance in Turner syndrome depending on age and karyotype. Eur J Pediatr 1988;148:64-68.
43. Ehm M, Karnoub M, Sakul H, Gottschalk K, Holt D, Weber J: Genomewide search for type 2 diabetes susceptibility genes. Am J Hum Genet 2000;66:1871-1881.
44. Kadowaki T: Insights into insulin resistance and type 2 diabetes from knock out mouse models. J Clin Invest 2000;106:459-465.
45. Gloyn A, McCarthy M: The genetics of type 2 diabetes. Best Prac Res Clin Endocrinol Metab 2001;15:293-308.